Psychiatry and Neurology, Neurology · Camden, NJ
NPI
1346266939
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3 Cooper Plz, Suite 215 (Neurology)
Camden, NJ, 08103
Phone (856) 342-2445
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
803 services
Medicare patients, 2024
533
Average age 67
Drug cost, 2024
$1.1M
7,976 prescriptions
Company payments, 2025
$1,327
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa A Carran was code 99214 (office e&m - established), 451 times for 316 patients. In total Melissa A Carran billed 803 services in 15 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 451 | 316 | $84.61 | $38K |
| 95720 Neurologic | Facility | 123 | 77 | $170.35 | $21K |
| 99204 Office E&M - New | Office | 81 | 81 | $120.64 | $9,771 |
| 95816 Neurologic | Facility | 32 | 28 | $45.05 | $1,441 |
| 95718 Neurologic | Facility | 28 | 27 | $110.88 | $3,105 |
| 95819 Neurologic | Facility | 27 | 24 | $46.57 | $1,257 |
| 95822 Neurologic | Facility | 21 | 20 | $44.31 | $931 |
| 99213 Office E&M - Established | Office | 21 | 19 | $62.48 | $1,312 |
By year: 2022 $71K for 785 services; 2023 $76K for 801 services; 2024 $79K for 803 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melissa A Carran prescribed most often to Medicare patients was Levetiracetam, with 978 prescriptions and refills. In total Melissa A Carran wrote 7,976 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 978 | 1,650 | 177 | $35K |
| Lacosamide Generic | 487 | 630 | 76 | $57K |
| Donepezil Hcl Generic | 427 | 851 | 108 | $4,512 |
| Memantine Hcl Generic | 399 | 754 | 90 | $12K |
| Topiramate Generic | 395 | 588 | 55 | $6,440 |
| Lamotrigine Generic | 381 | 601 | 59 | $7,202 |
| Zonisamide Generic | 344 | 440 | 46 | $11K |
| Divalproex Sodium Er Divalproex Sodium | 301 | 409 | 41 | $23K |
| Oxcarbazepine Generic | 278 | 415 | 46 | $29K |
| Clonazepam Generic | 239 | 254 | 42 | $2,327 |
| Divalproex Sodium Generic | 221 | 325 | 31 | $9,570 |
| Quetiapine Fumarate Generic | 197 | 285 | 35 | $3,180 |
| Phenobarbital Generic | 196 | 262 | 25 | $4,289 |
| Carbamazepine Er Carbamazepine | 162 | 254 | 26 | $29K |
| Trazodone Hcl Generic | 157 | 323 | 47 | $1,523 |
Brand drugs: 658 claims; generic drugs: 7,122 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa A Carran $1,327 ($1,327 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $395.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $395 |
| SK Life Science, Inc. | 8 | $161 |
| UCB, Inc. UCB.BR | 6 | $105 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $102 |
| Pfizer Inc. PFE | 5 | $101 |
| Aucta Pharmaceuticals, Inc. | 5 | $56.56 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $51.53 |
| Lundbeck LLC | 3 | $47.63 |
| Merz Pharmaceuticals, LLC | 2 | $47.59 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $39.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.